The research teams of Prof. Jiancheng Wang and Prof. Huaping Dai proposed a “Double Braking” strategy of nanomedicine on mitochondrial permeability transition pore for treating idiopathic pulmonary fibrosis
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research teams of Prof. Jiancheng Wang and Prof. Huaping Dai proposed a “Double Braking” strategy of nanomedicine on mitochondrial permeability transition pore for treating idiopathic pulmonary fibrosis[J]. Journal of Chinese Pharmaceutical Sciences, 2024, 33(11): 1099-1100.
>
>